The DOI matches its Crossref record; 37 of the 40 references it cites were found in a registry or an index, and 3 are not checked yet.
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Open accessAbstract
BACKGROUND: The most appropriate targets for systolic blood pressure to reduce cardiovascular morbidity and mortality among persons without diabetes remain uncertain. METHODS: We randomly assigned 9361 persons with a systolic blood pressure of 130 mm Hg or higher and an increased cardiovascular risk, but without diabetes, to a systolic blood-pressure target of less than 120 mm Hg (intensive treatment) or a target of less than 140 mm Hg (standard treatment). The primary composite outcome was myocardial infarction, other acute coronary syndromes, stroke, heart failure, or death from cardiovascular causes. RESULTS: At 1 year, the mean systolic blood pressure was 121.4 mm Hg in the intensive-treatment group and 136.2 mm Hg in the standard-treatment group. The intervention was stopped early after a median follow-up of 3.26 years owing to a significantly lower rate of the primary composite outcome in the intensive-treatment group than in the standard-treatment group (1.65% per year vs. 2.19% per year; hazard ratio with intensive treatment, 0.75; 95% confidence interval [CI], 0.64 to 0.89; P<0.001). All-cause mortality was also significantly lower in the intensive-treatment group (hazard ratio, 0.73; 95% CI, 0.60 to 0.90; P=0.003). Rates of serious adverse events of hypotension, syncope, electrolyte abnormalities, and acute kidney injury or failure, but not of injurious falls, were higher in the intensive-treatment group than in the standard-treatment group. CONCLUSIONS: Among patients at high risk for cardiovascular events but without diabetes, targeting a systolic blood pressure of less than 120 mm Hg, as compared with less than 140 mm Hg, resulted in lower rates of fatal and nonfatal major cardiovascular events and death from any cause, although significantly higher rates of some adverse events were observed in the intensive-treatment group. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT01206062.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the Systolic Blood Pressure Intervention Trial, 261 patients at high cardiovascular risk who were already using antihypertensive drugs targeting a systolic BP of 120 mmHg had an approximately twofold risk of syncope vs. the control group targeting a systolic BP of 140 mmHg.”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [261]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The results have been interpreted to be generally consistent between the two trials, but ACCORD BP was viewed as underpowered due to the composite primary end point being less sensitive to blood pressure regulation (38,40).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [38]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Adverse outcomes, including hypotension, syncope, electrolyte abnormality, and acute kidney injury (AKI), were more common in the intensive treatment arm; risk of adverse outcomes needs to be weighed against the cardiovascular benefit of more intensive blood pressure lowering.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“The primary composite outcome of MI, coronary syndromes, stroke, heart failure, or death from cardiovascular causes was reduced by 25% in the intensive treatment group.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated that treatment to a goal systolic blood pressure of <120 mmHg decreases cardiovascular event rates by 25% in high-risk individuals, although people with diabetes were excluded from this trial (38).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [38]
The cited source says what the claim attributes to it.
In the citing paper
“The results of BPROAD and ESPRIT are supported by the Systolic Blood Pressure Intervention Trial (SPRINT), which demonstrated that treatment to a goal systolic blood pressure of <120 mmHg decreases cardiovascular event rates by 25% in high-risk individuals, although people with diabetes were excluded from this trial (44).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“Adverse outcomes, including hypotension, syncope, electrolyte abnormality, and acute kidney injury (AKI), were more common in the intensive treatment arm”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [44]
In the citing paper
“in which there was a notable 25% relative/0.5% absolute reduced risk per year of cardiovascular morbidity and mortality with intensive (<120 mm Hg) as compared with standard (<140 mm Hg) systolic blood pressure control in patients with hypertension and high cardiovascular risk.71”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [71]
In the citing paper
“This graded approach is based on evidence from multiple meta-analyses and individual RCTs, which show a consistent and graded reduction in CVD risk in response to reductions in TC and LDL-C levels. 61-71”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [70]
In the citing paper
“These trials are consistent in showing that the higher the initial LDL-C level, the greater the absolute reduction in risk, while the relative risk reduction remains constant at any given baseline LDL-C level.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [70]
In the citing paper
“The primary composite outcome of myocardial infarction (MI), coronary syndromes, stroke, heart failure, or death from cardiovascular causes was reduced by 25% in the intensive treatment group.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [33]
In the citing paper
“The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated that treatment to a target systolic blood pressure of < 120 mmHg decreases cardiovascular event rates by 25% in high-risk patients, although people with diabetes were excluded from this trial (33).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [33]
In the citing paper
“Of note, the ACCORD BP and SPRINT trials targeted a similar systolic blood pressure < 120 mmHg, but in contrast to SPRINT, the primary composite cardiovascular end point was nonsigni fi cantly reduced in ACCORD BP.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [33]
In the citing paper
“The achieved systolic blood pressures in the trial were 121 mmHg and 136 mmHg in the intensive versus standard treatment group, respectively.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [33]
In the citing paper
“Adverse outcomes, including hypotension, syncope, electrolyte abnormality, and acute kidney injury were more common in the intensive treatment arm; risk of adverse outcomes needs to be weighed against the cardiovascular bene fi t of more intensive blood pressure lowering.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [33]
In the citing paper
“The results have been interpreted to be generally consistent between both trials, but ACCORD BP was viewed as underpowered due to the composite primary end point being less sensitive to blood pressure regulation (33).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,698
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Self-citationHeart Disease and Stroke Statistics—2014 Update
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2013) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,264
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Flagged first, then by citations
Research works printed but not linked: 3
- 10.1016/s0140-6736(05)70151-3 · DOI
- Franklin SS, 1999, Pathol Biol (Paris), 47, 594
- Nwankwo T, 2013, NCHS Data Brief, 133, 1
Cited by
Sorted by citations
Items 601–700 of 1,036
Clark, C. E., McDonagh, S. T. J., McManus, R. J., & Martin, U. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00451-x · Cited by 84
Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People
Lee, C. J., Lee, J.-Y., Han, K., Kim, D. H., Cho, H., Kim, K. J., Kang, E. S., Cha, B.-S., Lee, Y., & Park, S. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17283 · Cited by 84
McLean, R. M., & Wang, N. X. (2021) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2021.02.013 · Cited by 88
Judge, P. K., Tuttle, K. R., Staplin, N., Hauske, S. J., Zhu, D., Sardell, R. J., Cronin, L., Green, J. B., Agrawal, N., Arimoto, R., et al. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae263 · Cited by 84
Abdel-Qadir, H. M., Thavendiranathan, P., Austin, P. C., Lee, D. S., Amir, E., Tu, J. V., Fung, K., & Anderson, G. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy218 · Cited by 85
Muntner, P., & Whelton, P. K. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.066 · Cited by 83
Masked Hypertension: A Systematic Review
Thakkar, H. V., Pope, A., & Anpalahan, M. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.08.006 · Cited by 85
Bress, A. P., King, J. B., Kreider, K. E., Beddhu, S., Simmons, D. L., Cheung, A. K., Zhang, Y., Doumas, M. N., Nord, J. W., Sweeney, M. E., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0885 · Cited by 83
Rastegar, S., GholamHosseini, H., & Lowe, A. (2019) · Physical and Engineering Sciences in Medicine · doi:10.1007/s13246-019-00813-x · Cited by 83
A Machine Learning Approach to Management of Heart Failure Populations
Jing, L., Ulloa, A., Good, C. W., Sauers, N. M., Schneider, G., Hartzel, D. N., Leader, J. B., Kirchner, H. L., Hu, Y., Riviello, D., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2020.01.012 · Cited by 83
Wide pulse pressure: A clinical review
Tang, K. S., Medeiros, E., & Shah, A. D. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.14051 · Cited by 83
Aging and Renal Disease: Old Questions for New Challenges
Chou, Y., & Chen, Y. (2021) · Aging and Disease · doi:10.14336/ad.2020.0703 · Cited by 83
Kandzari, D. E., Mahfoud, F., Weber, M. A., Townsend, R., Parati, G., Fisher, N. D. L., Lobo, M. D., Bloch, M., Böhm, M., Sharp, A. S. P., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057687 · Cited by 83
Birtcher, K. K., Allen, L. A., Anderson, J. L., Bonaca, M. P., Gluckman, T. J., Hussain, A., Kosiborod, M., Mehta, L. S., & Virani, S. S. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.08.754 · Cited by 83
EMPA-REG – the “diuretic hypothesis”
McMurray, J. J. V. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.10.012 · Cited by 83
Ohya, Y., Arakawa, K., Arata, N., Arima, S., Arima, H., Asayama, K., Dohi, Y., Fukami, A., Furuhashi, M., Goto, K., et al. (2026) · Hypertension Research · doi:10.1038/s41440-025-02462-y · Cited by 91
Blood Pressure Management in Stroke
Gorelick, P. B., Whelton, P. K., Sorond, F., & Carey, R. M. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14653 · Cited by 82
Lettino, M., Mascherbauer, J., Nordaby, M., Ziegler, A., Collet, J., Dérumeaux, G., Hohnloser, S. H., Leclercq, C., O’Neill, D. E., Visseren, F. L. J., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac033 · Cited by 82
How to Manage Heart Failure With Preserved Ejection Fraction
Desai, A. S., Lam, C. S. P., McMurray, J. J. V., & Redfield, M. M. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.03.011 · Cited by 83
Managing Hypertension in Older Adults
Egan, B. M., Mattix-Kramer, H. J., Basile, J., & Sutherland, S. E. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01289-7 · Cited by 82
Life-course blood pressure in relation to brain volumes
Power, M. C., Schneider, A. L. C., Wruck, L., Griswold, M., Coker, L. H., Alonso, A., Jack, C. R., Knopman, D., Mosley, T. H., & Gottesman, R. F. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.012 · Cited by 81
Taylor, K. A., Wiles, J. D., Coleman, D. A., Leeson, P., Sharma, R., & O’Driscoll, J. M. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001922 · Cited by 81
Treatment of Acute Kidney Injury: A Review of Current Approaches and Emerging Innovations
Tamargo, C. L., Hanouneh, M. A., & Cervantes, C. E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092455 · Cited by 81
Sustained effects of a forest therapy program on the blood pressure of office workers
Song, C., Ikei, H., & Miyazaki, Y. (2017) · Urban forestry & urban greening · doi:10.1016/j.ufug.2017.08.015 · Cited by 81
New treatment paradigms for ADPKD: moving towards precision medicine
Lanktree, M. B., & Chapman, A. B. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.127 · Cited by 81
Langefeld, C. D., Comeau, M. E., Ng, M. C. Y., Guan, M., Dimitrov, L. M., Mudgal, P., Spainhour, M. H., Julian, B. A., Edberg, J. C., Croker, J. A., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.03.017 · Cited by 81
Medical and lifestyle management of peripheral arterial disease
Parvar, S., Fitridge, R., Dawson, J. A., & Nicholls, S. J. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.07.027 · Cited by 81
Gee, L. C., & Ahluwalia, A. (2016) · Current Hypertension Reports · doi:10.1007/s11906-015-0623-4 · Cited by 80
Zhang, Z., Chen, X., Lu, P., Zhang, J., Xu, Y., He, W., Li, M., Zhang, S., Jia, J., Shao, S., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0512-z · Cited by 80
Precision Medicine and Personalized Medicine in Cardiovascular Disease
Currie, G. E., & Delles, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77932-4_36 · Cited by 80
Pandey, A., Patel, K. V., Vongpatanasin, W., Ayers, C. R., Berry, J. D., Mentz, R. J., Blaha, M. J., McEvoy, J. W., Muntner, P., Vaduganathan, M., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.043337 · Cited by 80
Filardi, P. P., Coca, A., Galderisi, M., Paolillo, S., Alpendurada, F., SIMONE, G. D., Donal, E., Kahan, T., Mancia, G., Redón, J., et al. (2017) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jex094 · Cited by 80
Clinical Implications of the Revised AAP Pediatric Hypertension Guidelines
Khoury, M., Khoury, P. R., Dolan, L. M., Kimball, T. R., & Urbina, E. M. (2018) · PEDIATRICS · doi:10.1542/peds.2018-0245 · Cited by 80
Ferdinand, K. C., Balavoine, F., Besse, B., Black, H. R., Desbrandes, S., Dittrich, H. C., Nesbitt, S. D., & On behalf of the NEW HOPE Investigators (2019) · Circulation · doi:10.1161/circulationaha.119.040070 · Cited by 80
Effects of blood pressure lowering treatment in hypertension
Thomopoulos, C., Parati, G., & Zanchetti, A. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000972 · Cited by 79
Intervention against hypertension in the next generation programmed by developmental hypoxia
Brain, K. L., Allison, B. J., Niu, Y., Cross, C. M., Itani, N., Kane, A. D., Herrera, E. A., Skeffington, K. L., Botting, K. J., & Giussani, D. A. (2019) · PLoS Biology · doi:10.1371/journal.pbio.2006552 · Cited by 79
Sympathetic nervous system and hypertension: New evidences
Seravalle, G., & Grassi, G. M. (2022) · Autonomic Neuroscience · doi:10.1016/j.autneu.2022.102954 · Cited by 79
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 81
Comparison of Automated Office Blood Pressure With Office and Out-Off-Office Measurement Techniques
Pappaccogli, M., Monaco, S. D., Perlo, E., Burrello, J., D’Ascenzo, F., Veglio, F., Monticone, S., & Rabbia, F. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12079 · Cited by 78
Garimella, P. S., Lee, A. K., Ambrosius, W. T., Bhatt, U. Y., Cheung, A. K., Chonchol, M., Craven, T. E., Hawfield, A. T., Jotwani, V., Killeen, A. A., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz392 · Cited by 78
Epidemiology of Cardiovascular Diseases in the Elderly
Noale, M., Limongi, F., & Maggi, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-33330-0_4 · Cited by 78
Hypertension in adolescents: diagnosis, treatment, and implications
Khoury, M., & Urbina, E. M. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30344-8 · Cited by 78
Sex Differences in Hypertension and Its Management Throughout Life
Yeo, W.-J., Abraham, R., Surapaneni, A., Schlosser, P., Ballew, S. H., Özkan, B., Flaherty, C. M., Yu, B., Bonventre, J. V., Parikh, C. R., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.22980 · Cited by 78
Can Pediatric Hypertension Criteria Be Simplified?
Xi, B., Zhang, T., Li, S., Harville, E. W., Bazzano, L., He, J., & Chen, W. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08782 · Cited by 78
Böhm, M., Schumacher, H., Teo, K. K., Lonn, E., Mahfoud, F., Mann, J. F. E., Mancia, G., Redón, J., Schmieder, R. E., Marx, N., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz149 · Cited by 78
Nitric oxide deficiency is a primary driver of hypertension
Bryan, N. S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115325 · Cited by 77
Basu, S., Sussman, J. B., Rigdon, J., Steimle, L., Denton, B. T., & Hayward, R. A. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002410 · Cited by 77
Fuchs, S. C. P. C., Poli‐de‐Figueiredo, C. E., Neto, J. A. D. F., Scala, L. C. N., Whelton, P. K., Mosele, F., de Mello, R. G. B., Vilela-Martin, J. F., Moreira, L. B., Chaves, H., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004248 · Cited by 77
Antihypertensive Treatment Fails to Control Blood Pressure During Exercise
Chant, B., Bakali, M., Hinton, T., Burchell, A. E., Nightingale, A. K., Paton, J. F. R., & Hart, E. C. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11076 · Cited by 77
Validating cuffless continuous blood pressure monitoring devices
Hu, J., Martin, G., Iyengar, S., Kovell, L. C., Plante, T. B., van Helmond, N., Dart, R. A., Brady, T. M., Turkson‐Ocran, R., & Juraschek, S. P. (2023) · Cardiovascular Digital Health Journal · doi:10.1016/j.cvdhj.2023.01.001 · Cited by 77
Weiner, D. E., Gaussoin, S. A., Nord, J. W., Auchus, A. P., Chelune, G. J., Chonchol, M., Coker, L. H., Haley, W. E., Killeen, A. A., Kimmel, P. L., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.04.021 · Cited by 77
Douros, A., Tölle, M., Ebert, N., Gaedeke, J., Huscher, D., Kreutz, R. H., Kuhlmann, M. K., Martus, P., Mielke, N., Schneider, A., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz071 · Cited by 77
Prevention of Hypertension Related to Cardiovascular Disease
Perumareddi, P. (2018) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2018.10.005 · Cited by 76
Shang, N., Khan, A., Polubriaginof, F. C. G., Zanoni, F., Mehl, K., Fasel, D. A., Drawz, P. E., Caroll, R. J., Denny, J. C., Hathcock, M. A., et al. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00428-1 · Cited by 76
Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow
Dolui, S., Detre, J. A., Gaussoin, S. A., Herrick, J. S., Wang, D. J. J., Tamura, M. K., Cho, M. E., Haley, W. E., Launer, L. J., Punzi, H. A., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.0074 · Cited by 76
Peralta, C. A., McClure, L. A., Scherzer, R., Odden, M. C., White, C. L., Shlipak, M. G., Benavente, O., & Pérgola, P. E. (2016) · Circulation · doi:10.1161/circulationaha.115.019657 · Cited by 76
Bangalore, S., Fayyad, R. S., Messerli, F. H., Laskey, R. E., DeMicco, D. A., Kastelein, J. J. P., & Waters, D. D. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.10.037 · Cited by 76
Fengler, K., Ewen, S., Höllriegel, R., Rommel, K., Kulenthiran, S., Lauder, L., Cremers, B., Schuler, G. C., Linke, A., Böhm, M., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006196 · Cited by 76
Khan, S. S., Breathett, K., Braun, L. T., Chow, S. L., Gupta, D. K., Lekavich, C., Lloyd-Jones, D. M., Ndumele, C. E., Rodriguez, C. J., Allen, L. A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001307 · Cited by 75
Eryd, S. A., Guðbjörnsdóttir, S., Manhem, K., Rosengren, A., Svensson, A., Miftaraj, M., Franzén, S., & Björck, S. (2016) · BMJ · doi:10.1136/bmj.i4070 · Cited by 75
Blood Pressure Measurement Anno 2016
Staessen, J. A., Li, Y., Hara, A., Asayama, K., Dolan, E., & O'Brien, E. T. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpw148 · Cited by 75
Hypertension and diabetes mellitus: highlights of a complex relationship
Yildiz, M., Esenboğa, K., & Oktay, A. A. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000748 · Cited by 75
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
Arundel, C., Lam, P. H., Gill, G. S., Patel, S. S., Panjrath, G. S., Faselis, C. J., White, M., Morgan, C. J., Allman, R. M., Aronow, W. S., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.022 · Cited by 75
de Pinho, N. A., Levin, A., Fukagawa, M., Hoy, W. E., Pecoits‐Filho, R., Reichel, H., Robinson, B. M., Kitiyakara, C., Wang, J., Eckardt, K., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.04.032 · Cited by 75
Zhou, W., Brown, J. M., Bajaj, N. S., Chandra, A., Divakaran, S., Weber, B., Bibbo, C. F., Hainer, J. M., Taqueti, V. R., Dorbala, S., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa191 · Cited by 75
Kaneko, H., Itoh, H., Yotsumoto, H., Kiriyama, H., Kamon, T., Fujiu, K., Morita, K., Michihata, N., Jo, T., Takeda, N., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017963 · Cited by 74
Cheung, A. K., Chang, T. I., Cushman, W. C., Furth, S. L., Ix, J. H., Pecoits‐Filho, R., Perkovic, V., Sarnak, M. J., Tobe, S. W., Tomson, C., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.12.025 · Cited by 74
Persistence of myopathy in Cushing’s syndrome: evaluation of the German Cushing’s Registry
Berr, C., Stieg, M. R., Deutschbein, T., Quinkler, M. O., Schmidmaier, R., Oßwald, A., Reisch, N., Ritzel, K., Dimopoulou, C., Fazel, J., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0689 · Cited by 74
Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg
Tajeu, G. S., Booth, J. N., Colantonio, L. D., Gottesman, R. F., Howard, G., Lackland, D. T., O'Brien, E. C., Oparil, S., Ravenell, J. E., Safford, M. M., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027362 · Cited by 74
Chua, J., Chin, C. W. L., Tan, B., Wong, S. H., Devarajan, K., Le, T., Ang, M., Wong, T. Y., & Schmetterer, L. F. (2019) · Scientific Reports · doi:10.1038/s41598-019-41917-4 · Cited by 74
2017 Pediatric Hypertension Guidelines Improve Prediction of Adult Cardiovascular Outcomes
Du, T., Fernandez, C., Barshop, R., Chen, W., Urbina, E. M., & Bazzano, L. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12469 · Cited by 73
Li, J., Somers, V. K., Gao, X., Chen, Z., Ju, J., Lin, Q., Mohamed, E. A., Karim, S., Xu, H. F., & Zhang, L. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.37554 · Cited by 73
Piepoli, M. F., Adamo, M., Barison, A., Bestetti, R. B., Biegus, J., Böhm, M., Butler, J., Carapetis, J. R., Ceconi, C., Chioncel, O. D., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2351 · Cited by 73
The two faces of hypertension: role of aortic stiffness
Smulyan, H., Mookherjee, S., & Safar, M. E. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.11.012 · Cited by 73
Hallan, S. I., Øvrehus, M. A., Romundstad, S., Rifkin, D. E., Langhammer, A., Stevens, P. E., & Ix, J. H. (2016) · Kidney International · doi:10.1016/j.kint.2016.04.012 · Cited by 73
Guidelines on the management of arterial hypertension and related comorbidities in Latin America
Task Force of the Latin American Society of Hypertension (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001418 · Cited by 73
Cardiovascular Disease and Diabetic Kidney Disease
Maqbool, M., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.02.003 · Cited by 73
Keller, K., Stelzer, K., Ostad, M. A., & Post, F. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2016.11.010 · Cited by 72
Nasrallah, I. M., Gaussoin, S. A., Pomponio, R., Dolui, S., Erus, G., Wright, C. B., Launer, L. J., Detre, J. A., Wolk, D. A., Davatzikos, C. A., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.0178 · Cited by 72
Evaluating Treatment Prioritization Rules via Rank-Weighted Average Treatment Effects
Yadlowsky, S., Fleming, S. L., Shah, N. H., Brunskill, E., & Wager, S. (2024) · Journal of the American Statistical Association · doi:10.1080/01621459.2024.2393466 · Cited by 72
Hypertension and Heart Failure
Palo, K. E. D., & Barone, N. J. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2021.12.011 · Cited by 72
Vidal‐Petiot, E., Stebbins, A., Chiswell, K., Ardissino, D., Aylward, P. E., Cannon, C. P., Corrales, M. A. R., Held, C., López-Sendón, J. L., Stewart, R., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx250 · Cited by 72
Nzelu, D., Dumitrascu‐Biris, D., Nicolaides, K. H., & Kametas, N. A. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.235 · Cited by 72
Tsioufis, K. P., Kreutz, R. H., Sykara, G. D., van Vugt, J., & Hassan, T. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002381 · Cited by 72
Momeni, J., Omidi, A., Raygan, F., & Akbari, H. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.07.007 · Cited by 71
Leeman, M., & Kestelyn, P. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.11507 · Cited by 71
Variation in hypertension clinical practice guidelines: a global comparison
Philip, R., Beaney, T. E., Appelbaum, N., Gonzálvez, C. R., Koldeweij, C., Golestaneh, A. K., Poulter, N. R., & Clarke, J. (2021) · BMC Medicine · doi:10.1186/s12916-021-01963-0 · Cited by 71
2023 Guidelines on the management of patients with diabetes - a position of Diabetes Poland
Araszkiewicz, A., Bandurska-Stankiewicz, E. M., Borys, S., Budzynski, A. Z., Cyganek, K., Cypryk, K., Czech, A., Czupryniak, L., Drzewoski, J., Dzida, G. J., et al. (2023) · Current Topics in Diabetes · doi:10.5114/ctd/160061 · Cited by 72
Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity
Brewster, L. M., van Montfrans, G. A., Oehlers, G. P., & Seedat, Y. K. (2016) · Internal and Emergency Medicine · doi:10.1007/s11739-016-1422-x · Cited by 71
Eriksen, B. O., Stefansson, V. T. N., Jenssen, T. G., Mathisen, U. D., Schei, J., Solbu, M. D., Wilsgaard, T., & Melsom, T. (2016) · Kidney International · doi:10.1016/j.kint.2016.03.021 · Cited by 71
Denervation of the distal renal arterial branches vs. conventional main renal artery treatment
Pekarskiy, S. E., Baev, A. E., Mordovin, V. F., Semke, G. V., Ripp, T. M., Falkovskaya, А. Y., Lichikaki, V. A., Sitkova, E. S., Zyubanova, I. V., & Popov, S. V. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001160 · Cited by 71
Choi, Y.-J., Kim, S., Kang, S., Yoon, C., Lee, H., Youn, T., Chae, I., & Kim, C. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy801 · Cited by 71
Treatment of Hypertension in Patients with Asthma
Christiansen, S. C., & Zuraw, B. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1800345 · Cited by 71
Does Chronic Kidney Disease Predict Stroke Risk Independent of Blood Pressure?
Kelly, D., & Rothwell, P. M. (2019) · Stroke · doi:10.1161/strokeaha.119.025442 · Cited by 70
Sex steroids receptors, hypertension, and vascular ageing
Connelly, P. J., Casey, H., Montezano, A. C. I., Touyz, R. M., & Delles, C. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-021-00576-7 · Cited by 70
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
Saiz, L. C., Gorricho, J., Garjón, J., Celaya, M. C., Erviti, J., & Leache, L. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010315.pub4 · Cited by 70
Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases
Mu, D., Cheng, J. H., Qiu, L., & Cheng, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.901990 · Cited by 70
BP in Dialysis: Results of a Pilot Study
Miskulin, D. C., Gassman, J., Schrader, R., Gul, A., Jhamb, M., Ploth, D. W., Negrea, L. A., Kwong, R. Y. K., Levey, A. S., Singh, A. K., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017020135 · Cited by 70
Blood pressure targets for hypertension in older adults
Garrison, S., Kolber, M. R., Korownyk, C. S., McCracken, R., Heran, B. S., & Allan, G. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011575.pub2 · Cited by 69
Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span
Vaduganathan, M., Claggett, B. L., Juraschek, S. P., & Solomon, S. D. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2019.6192 · Cited by 69
Metadata
- Authors
- The SPRINT Research Group
- Affiliations
- University Hospitals Cleveland Medical Center (US)
- Corresponding author
- The SPRINT Research Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-11-26
- Volume
- 373
- Issue
- 22
- Pages
- 2103-2116
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4689591
- OpenAlex
- W3150595609
- Cited by
- 6,325
- References
- 38
- Citations by year
- 2026: 390 · 2025: 449 · 2024: 437 · 2023: 498 · 2022: 523 · 2021: 602 · 2020: 570 · 2019: 694 · 2018: 734 · 2017: 767 · 2016: 613 · 2015: 40
- FWCI
- 522.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000093, UL1TR000050, UL1TR001427, UL1TR000073, UL1TR001064, UL1TR001085, UL1TR000002, UL1TR000075, UL1TR000064, UL1TR000005, UL1TR000433, UL1TR000003, UL1TR000445, UL1TR000439, UL1TR000105)
- National Institute on Aging (P30AG021332)
- National Heart, Lung, and Blood Institute (HHSN268200900040C, A-HL-13-002-001, HHSN268200900049C, HHSN268200900048C, HHSN268200900047C, HHSN268200900046C)
- National Institute of General Medical Sciences (P30GM103337)
- National Center for Research Resources (UL1RR025755, UL1RR024134, UL1RR025752, UL1RR025771)
- National Center for Advancing Translational Sciences (9U54TR000017‐06)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- intensive blood pressure control, systolic blood pressure target, antihypertensive therapy, cardiovascular risk, cardiovascular events, all-cause mortality, adverse events, hypotension, acute kidney injury, non-diabetic patients
- MeSH terms
- Age Factors, Aged, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Cause of Death, Female, Goals, Humans, Hypertension, Male, Middle Aged, Risk Factors, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
